of Children’s Cancer Institute and UNSW
Featured Article Blocking copper uptake in tumour cells may be clue to boosting immune system – fighting the deadliest of cancers.
While immunotherapy, a treatment that works through a patient’s immune system to kill the cancers, has proven to be a breakthrough for many cancer patients, offering real hope and for some even a.
Blocking copper uptake in tumour cells may be clue to boosting immune system – fighting the deadliest of cancers.
August 7, 2020 Australian researchers have discovered how an affordable and currently available drug – which removes copper from the blood can destroy some of the deadliest cancers that are resistant to immunotherapy.
Targeting stem cells: the path to curing poor-prognosis leukaemia.
June 19, 2020 Researchers at Children’s Cancer Institute have discovered what could prove a new and improved way to treat the poor-prognosis blood cancer, acute myeloid leukaemia or AML.
Australia to lead world-first trial in children with brain cancer.
June 9, 2020 Australia will join an international clinical trial to test a new treatment in children with brain cancer, due to launch later this year.
$67m Funding Collaboration: All Australian Children with Cancer to Access World Class
April 30, 2020 The Commonwealth Government together with Minderoo Foundation today announced funding of $67 million to expand the international ly recognised Zero Childhood Cancer personalised medicine program (ZERO) – ensuring all Australian children and young people diagnosed with cancer are given the greatest chance of survival.
Townsville to Cairns Bike Ride cancelled.
March 31, 2020 For the health and wellbeing of our community , we regret to announce that the 2020 Townsville to Cairns Bike Ride is cancelled.
An update on our life-saving research.
March 25, 2020 An update from Professor Michelle Haber AM, .
Executive Director of Children’s Cancer InstituteMore
Children’s cancer researcher awarded NSW Premier’s Woman of the Year .
March 5, 2020 Professor Maria Kavallaris AM, a leading childhood cancer researcher and a pioneer of nanomedicine in Australia, has been announced as the 2020 NSW Premier’s Woman of the Year.
International research collaboration reveals promising drug candidate for treatment of blood cancers.
January 16, 2020 An international research collaboration between the United States and Australia has revealed a promising new drug which could treat high-risk leukaemia.
New therapy shows ‘dramatic’ effect against worst leukaemias.
December 10, 2019 A collaborative research effort by Australian and US scientists has led to the discovery of a promising new approach to treating some of the worst types of leukaemia, including an aggressive leukaemia that mostly affects babies.
Researchers find new way to target childhood cancer.
November 18, 2019 An Australian-led international research effort has broken fresh ground in the race to find more effective treatments for the childhood cancer neuroblastoma.
Children’s Cancer Institute welcome the Governor-General and Linda Hurley as Patrons
September 4, 2019 Children’s Cancer Institute is pleased to welcome His Excellency General the Honourable David Hurley AC DSC (Retd), Governor-General of Australia and Mrs Hurley as Patrons.
New gene found for a deadly childhood cancer offers possibility of targeted drug therapy.
July 31, 2019 Australian researchers from Children’s Cancer Institute have discovered a gene that plays an important role in the childhood cancer neuroblastoma, and have developed a targeted therapy against it.
Australian researchers find chink in the armour of one of the most aggressive leukaemia types.
July 28, 2019 A team from Children’s Cancer Institute has found a drug that offers new hope to infants with one of the most aggressive forms of leukaemia.
New research paves the way for safer leukaemia treatments.
May 30, 2019 An international team of researchers has discovered a new and much safer way to treat a type of leukaemia that mainly affects children: T-cell acute lymphoblastic leukemia (T-ALL).
Minderoo Foundation’s $5 million donation to Zero Childhood Cancer will help kids like Jack beat brain cancer.
May 15, 2019 Today Minderoo Foundation’s Eliminate Cancer initiative announced a $5 million partnership with Zero to help scale the program in Australia, drive further research into personalised medicine in childhood cancer and help established standardised international protocols.
Childhood cancer scientist rewarded for research excellence.
April 1, 2019 Children’s Cancer Institute researcher Professor Maria Kavallaris AM – who in January this year was appointed a Member of the Order of Australia for her significant service to medicine and to medical research – today received further recognition for her work, winning the prestigious Lemberg Medal.
Leading children’s cancer scientist awarded for outstanding research.
March 15, 2019 Professor Murray Norris AM, Deputy Director of Children’s Cancer Institute and Director of the Centre for Childhood Cancer Research at the University of New South Wales, has won the inaugural Sally Crossing AM Award for an Outstanding Outcome in Cancer Research.
World-Class Comprehensive Children’s Cancer Centre Announced.
March 1, 2019 State and Commonwealth Health Ministers, Brad Hazzard and Greg Hunt, announce that a new, world-class Comprehensive Children’s Cancer Centre will be built on the Randwick Hospital Campus, as a new home for Children’s Cancer Institute, and also for an expanded Kid’s Cancer Centre at Sydney Children’s Hospital.
Australian Scientists Discover a Potential Way to Treat and Prevent Cancer in Children with Neuroblastoma.
February 1, 2019 In new research published this week, a team jointly led by Professors Michelle Haber and Murray Norris has revealed that the polyamine pathway is entirely regulated by the MYCN oncogeneMore.
Maria Kavallaris receives Order of Australia.
January 26, 2019 Children’s Cancer Institute is thrilled to announce that Professor Maria Kavallaris – a leading childhood cancer researcher and a pioneer of nanomedicine in Australia – is to be appointed a Member of the Order of Australia.
She will be included in the 2019 Australia Day Honours List for her significant service to medicine, and to medical research, in the field of childhood and adult cancers.
For children with the most common childhood cancer, resistance to treatment has remained an enigma – until now.
December 17, 2018 Research published last week in the prestigious journal, Cancer Cell, by scientists at Children’s Cancer Institute in Sydney, has discovered why one of the most successful classes of drugs used to treat acute lymphoblastic leukaemia (ALL), glucocorticoids, fails to work in 15% of children with the disease.
How Targeting Copper Levels in Tumours Could Hold Key to One of the Deadliest Childhood Cancers.
November 19, 2018 Tumour cells are known to have high levels of copper.
Now researchers at Children’s Cancer Institute in Sydney have found that an antioxidant found in green tea can kill tumour cells by targeting only those with high levels of the metal without harming the healthy cells around them.
Media Release: ‘Zero Childhood Cancer’ Clinical Trial Delivers Promising Results Within Its First 11 Months.
September 2, 2018 The Zero Childhood Cancer program has today released initial results of its national clinical trial, revealing promising outcomes within its first 11 months.
Children’s Cancer Institute’s Michelle Haber recognised with a Eureka Nomination
July 25, 2018 Cancer is diagnosed in more than 950 children and adolescents in Australia every year.
Professor Michelle Haber AM, of Children’s Cancer Institute and UNSW, was today announced as a finalist for the 2018 Australian Museum Eureka Prize for Leadership in Innovation and Science, sponsored by CSIRO, for her pivotal work in developing the Zero Childhood Cancer program.
The program was designed specifically to ensure that those children diagnosed with aggressive cancer have the best possible chance of surviving and doing so with a high quality of life.
Media Release: Prime Minister announces $5 million funding boost for brain cancer personalised trials.
July 16, 2018 The Zero Childhood Cancer personalised medicine program is the largest single initiative ever undertaken for children with cancer in AustraliaMore.
Curing Childhood Cancer – a Global Approach to Improve Cancer Treatment.
July 12, 2018 This week in the United States, a database of genetic information will be made publicly available of more than 270 patient-derived cancer models, encompassing 25 different childhood cancers.
Assisted by funding from the Australian Federal Government Department of Health, .
Children’s Cancer Institute contributed 90 leukaemia models to this global effort
NANO-STARS – TARGETING A DEADLY CHILDHOOD BRAIN CANCER.
June 27, 2018 At the International Nanomedicine Conference in Sydney (25-27 June), Helen Forgham, from Children’s Cancer Institute, is presenting a new technology for targeting the childhood brain cancer medulloblastoma.
She’s using star-shaped nanoparticles to deliver gene silencing drugs to tumour cells.
New hope for children’s brain cancer.
April 18, 2018 There is a disease that kills children aged between 5 and 10 years old, within one year of diagnosis.
New research to be presented at an international conference this week may be about to change that.
Sydney researchers find a way to target and kill one of the deadliest childhood cancers.
March 12, 2018 In the pursuit to cure cancer, scientists have long dreamed of a ‘magic bullet’ to eliminate diseased cells without harming healthy tissue.
Now researchers at Children’s Cancer Institute have discovered a way to treat the deadly children cancer, neuroblastoma, that increases the chances of killing the cancer, while reducing the short and long term toxic side effects of current therapy.
Missing DNA fragments hold clue to predicting childhood leukaemia relapse.
December 1, 2017 Australian researchers have developed a new risk scoring system for children with leukaemia based on missing DNA fragments or ‘microdeletions’.
Childhood cancer leader’s star on the rise at NSW Premier’s Science and Engineering Prizes.
October 23, 2017 Professor Maria Kavallaris, has won a 2017 NSW Premier’s Prize for Science and Engineering.
Grant to speed development of treatments to overcome cancer drug resistance.
October 17, 2017 Researchers have been awarded a 3-year $840K Development Grant to test inhibitors of MRP1, a protein which ejects chemotherapy drugs from cancer cells, in a bid to improve patient survival.
Children with most aggressive cancers to benefit from Australian-first personalised medicine clinical trial.
September 18, 2017 Personalised medicine for childhood cancers in Australia is a step closer thanks to the Zero Childhood Cancer program’s national clinical trial launched today.
Tumour blood supply stopped in its tracks.
August 9, 2017 Researchers have discovered how a modified natural compound disrupts angiogenesis, the formation of blood vessel networks, in neuroblastoma tumours, stopping them laying down the vital supply lines that fuel cancer growth and spread.
Leader in childhood cancer research a Eureka Prize finalist.
July 28, 2017 Professor Michelle Haber AM, of Children’s Cancer Institute and UNSW, was today announced as a finalist for the 2017 Australian Museum Eureka Prize for Leadership in Innovation and Science, sponsored by CSIRO.
$1.3M for neuroblastoma treatments.
February 15, 2017 Three grants totalling almost $1.3 million have been awarded to researchers from Children’s Cancer Institute to investigate new treatments for neuroblastoma.
Treatment search for neuroblastoma gets $6.6M boost.
February 8, 2017 New treatment approaches could emerge from research into the cancer that claims more lives of under 5s than any otherMore.
NSW to become world leader in paediatric research with Australia-first collaboration.
December 13, 2016 Introducing Paediatrio, an innovative joint venture that will enable NSW to set the national agenda for child health.
NHMRC support for exciting new children’s cancer research.
December 8, 2016 The search for improved treatments for children’s cancers, including innovative research into a currently incurable brain cancer, will take a big step forward as the NHMRC announced funding totalling $4.5M for Children’s Cancer Institute.
$20M from Federal Government for Personalised Medicine Program Zero Childhood Cancer.
November 3, 2016 The Prime Minister presented a cheque today for $20M to support Australia’s single-biggest initiative in childhood cancer research, the Zero Childhood Cancer national child cancer personalised medicine program.
Professor Maria Kavallaris elected AAHMS Fellow.
October 7, 2016 Professor Maria Kavallaris of Children’s Cancer Institute has been inducted as a Fellow of the Australian Academy of Health and Medical Sciences (AAHMS).
Children’s Cancer Institute celebrates 40th anniversary.
September 29, 2016 In 1975, two parents heard some of the most devastating words imaginable, “Your child has cancer.”More.
Blood ‘hot study’ shows potential for leukaemia drug.
September 26, 2016 A ‘breakthrough’ adult leukaemia therapy called venetoclax could successfully target high-risk leukaemia subtypes in infants or children reveals an Australian study published this month, Childhood Cancer Awareness Month, in prestigious US haematology journal Blood.
Robots play major role in tailoring treatment for kids’ high-risk cancers.
September 2, 2016 Thanks to a $1.5M grant from the Australian Cancer Research Foundation (ACRF), the new ACRF Child Cancer Personalised Medicine Centre’s specialised robots can now rapidly test hundreds of treatments for kids with high-risk cancers to guide their care.
Fresh look at cancer’s secret of eternal youth.
August 18, 2016 Recent advances in drug discovery technology and molecular studies could yield a suite of potential drugs that target cancer’s secret of eternal youth, argue Australian researchers in a Nature Reviews Cancer paper this month.
Disruptive protein opens doors to spread tumours.
June 21, 2016 Much like the remote control on a garage door, stathmin sends signals that let cancer cells into and out of blood vessels.
Childhood cancer cells face testing future.
June 19, 2016 In the future, simple blood tests for circulating tumour cells or DNA could be an efficient and non-invasive way to track changes in patients with one of childhood’s more common cancers, neuroblastoma.
Bench to bedside research for childhood cancer gets funding boost.
June 9, 2016 Children’s Cancer Institute, one of six partners in the Kids Cancer Alliance, was a major recipient of translational research grants from the Cancer Institute NSW.
Prime Minister announces major funding commitment for Zero Childhood Cancer.
May 31, 2016 We are delighted that the Prime Minister has announced today a $20M funding commitment for Australia’s single-biggest initiative in childhood cancer, the Zero Childhood Cancer Program.
Landmark Lions project to provide genome sequencing to hundreds of Aussie kids with cancer.
May 14, 2016 Children’s Cancer Institute is proud to share the news that hundreds of Australian children with high-risk cancer will have access to new genome sequencing technologies that could guide their treatment, following the announcement today of substantial Lions Club funding for the Lions Kids Cancer Genome Project – an important new component of the Zero Childhood Cancer Program for diagnosis and treatment of childhood cancer.
Old drug may offer new hope to cancer patients.
March 10, 2016 Who says you can’t teach an old dog new tricks.
It seems drugs that have been around for years can sometimes do something spectacular when applied in a whole new way.
Cancer Council NSW Program Grant funds our multi-faceted leukaemia research.
December 19, 2015 Cancer Council NSW has awarded Children’s Cancer Institute its fourth consecutive 5-year Program Grant to research ways of improving treatments for children with ‘refractory’ acute lymphoblastic leukaemia (ALL) – in other words, children diagnosed with a high-risk subtype of the disease, or who have received treatment and have subsequently relapsed.
Notice of change of Auditor.
December 14, 2015 Children’s Cancer Institute (‘the Institute’) hereby advises that the Australian Securities and Investments Commission (ASIC) have consented to the resignation of the Institute’s auditors, Moore Stephens, effective from the date of the attached notice.
Professor Maria Kavallaris one of ‘The Knowledge Nation 100’.
December 10, 2015 Professor Maria Kavallaris from Children’s Cancer Institute has been recognised as one of ‘The Knowledge Nation 100’ – Australia’s top 100 “visionaries, intellects, founders and game changers” who will help shape the country’s future prosperity.
Promising child cancer researchers supported by Balnaves Foundation.
2015 Two inspiring postdoctoral researchers from Children’s Cancer Institute
Dr Daniel Carter and Dr Duohui (Vincent) Jing, are recipients of the 2015 Balnaves Foundation Young Researcher’s Fund.
The Balnaves Foundation, a private philanthropic organisation set up by Neil Balnaves AO in 2006, has awarded each researcher $100,000 to explore uncharted territory in childhood cancer.
A way to target the Achilles heel of neuroblastoma.
November 5, 2015 Australian scientists have identified a critical molecular ‘feedback loop’ that helps initiate and drive neuroblastoma, a cancer of the nervous system in children that is triggered in embryonal nerve cells.
Our finest researchers among finalists in The Australian Innovation Challenge.
October 24, 2015 A team of inspirational child cancer researchers – Professors Glenn Marshall, Michelle Haber and Murray Norris – have been selected as finalists in the Health category of The Australian Innovation Challenge, announced in The Australian newspaper today.
Professor Maria Kavallaris one of The Australian Financial Review and Westpac’s 100 Women of Influence 2015.
September 24, 2015 Professor Maria Kavallaris.
Head of the Tumour Biology & Targeting Program at Children’s Cancer Institute
and founding Director of the Australian Centre for NanoMedicine at UNSW Australia, has been named one of The Australian Financial Review and Westpac’s 100 Women of Influence 2015.
Fast-tracking new drugs for childhood acute leukaemia.
September 9, 2015 Children’s Cancer Institute welcomes its inclusion, by the US National Cancer Institute (NCI), in a systematic program of drug evaluation in childhood cancer.
Zero Childhood Cancer program aims to push survival rates to 100%.
September 2, 2015 Children’s Cancer Institute and Sydney Children’s Hospital, Randwick (part of The Sydney Children’s Hospitals Network) are proud to announce one of the most exciting childhood cancer research initiatives ever undertaken in Australia, to tackle the most serious cases of infant, childhood and adolescent cancer.
Launched today at Children’s Cancer Institute, ‘Zero Childhood Cancer’ gives hope to children with the highest risk of treatment failure or relapse.
Professor Maria Kavallaris appointed to NHMRC Research Committee.
August 25, 2015 The CEO of the NHMRC Professor Anne Kelso, today announced the appointment of Professor Maria Kavallaris, Head of the Tumour Biology & Targeting Program at Children’s Cancer Institute, to the Research Committee of the National Health and Medical Research Council (NHMRC).
Research sector celebrates passage of Medical Research Future Fund Bill.
August 12, 2015 Today’s passing of the legislation for the Medical Research Future Fund (MRFF) in the Senate has brought hope not just to the Australian health and medical research sector but also to the entire country, according to the Association of Australian Medical Research Institutes (AAMRI).
Children’s Cancer Institute signs MoU with Peter Mac.
July 21, 2015 Children’s Cancer Institute is delighted to announce the strengthening and formalisation of its relationship with Melbourne’s Peter MacCallum Cancer Centre through a Memorandum of Understanding (MoU) that specifies areas of collaboration in cancer research for children and adolescents.
Promising drug for childhood acute leukaemia – where to next.
July 10, 2015 A new Australian study shows that a recently-developed drug, already used safely in adult leukaemia clinical trials1, holds great promise for some children with an aggressive form of cancer known as acute lymphoblastic leukaemia (ALL).
25 Million for Paediatric Research.
June 18, 2015 Minister for Health Jillian Skinner and Minister for Medical Research Pru Goward have visited The Children’s Hospital at Westmead to announce the 2015-16 Budget will include $25 million for paediatric research to unlock treatments and cures.
Deputy Director appointed AM.
2015 Children’s Cancer Institute is thrilled to announce that our Deputy Director
Professor Murray Norris, has been appointed a Member of the Order of Australia as part of the 2015 Queen’s Birthday Honours List for outstanding achievement and contribution in the field of childhood cancer research.
Children’s Cancer Institute and The Cure Starts Now join forces.
March 27, 2015 Townsville based cancer research foundation, The Cure Starts Now (Australia), has granted Children’s Cancer Institute another $100,000 to expand research in to Diffuse Intrinsic Pontine Glioma (DIPG) – the most aggressive and deadly of all childhood cancers.
Michelle Haber inaugural fellow AAHMS.
2015 Children’s Cancer Institute is pleased to announce that our Executive Director
Professor Michelle Haber AM, has been elected as a Fellow of the newly formed Australian Academy of Health & Medical Sciences (AAHMS).
Children’s Cancer Institute awarded grant by NHMRC.
March 25, 2015 A team led by Children’s Cancer Institute researchers has been awarded a grant by the National Health & Medical Research Council (NHMRC), announced today by the Minister for Health, the Hon Sussan Ley MP, for its innovative work into two of the most aggressive types of childhood cancer.
Cancer Institute NSW Program Grants.
March 5, 2015 Children’s Cancer Institute’s outstanding research work has been recognised by the Cancer Institute NSW’s Translational Program Grants, announced yesterday by NSW Minister for Health and Medical Research, The Hon Jillian Skinner MP.
Drug pinpointed for aggressive leukaemia.
February 26, 2015 Children’s Cancer Institute researchers have identified a drug as a potential treatment for a particularly aggressive, chemotherapy-resistant type of paediatric leukaemia.
State wide investment in child research.
February 24, 2015 Children’s Cancer Institute is delighted to be one of three recipients of a ground-breaking investment by the state government into paediatric medical research.
Balnaves award to two researchers.
February 9, 2015 The Balnaves Foundation has once again shown its commitment to curing childhood cancer by awarding two aspiring researchers at Children’s Cancer Institute the Balnaves Young Researcher of the Year Award 2014.
Commitment to MRFF.
December 15, 2014 Children’s Cancer Institute has welcomed the announcement by the Prime Minister and the Minister for Health of a new funding package to see the $20 billion Medical Research Future Fund (MRFF) realised.
Cancer stem cell world first.
December 12, 2014 Children’s Cancer Institute researchers have identified, for the first time, new properties essential to drug-resistant tumour cells that could revolutionise cancer treatment and reduce the side-effects of chemotherapy.
Australian first child cancer medicine centre.
November 13, 2014 Children’s Cancer Institute has been awarded a grant of $1.5 million for the establishment of a precision medicine centre.
The centre heralds a new era in childhood cancer research and treatment and has the very real potential to substantially improve patient outcomes and survival rates.
Milestone hit on journey to a cure.
November 7, 2014 Researchers have made an important step towards a 100% survival rate for the most common type of childhood cancer, with the latest findings of a trial for children with relapsed acute lymphoblastic leukaemia confirming the superiority of a chemotherapy drug for treating the disease.
New drug potential for child leukaemia.
October 17, 2014 Researchers from Children’s Cancer Institute have uncovered a potential new treatment for acute lymphoblastic leukaemia – the most common form of childhood cancer.
Abcam licenses MRP4 from Institute.
September 19, 2014 Compounds allow further exploration of MRP4 function and have potential in cancer therapeutic developmentMore.
Ground breaking clinical trial for childhood cancer.
September 2, 2014 New trial offers exciting new treatment approach for aggressive relapsed neuroblastomaMore.
Michelle Haber wins top award.
August 23, 2014 Children’s Cancer Institute is thrilled to announce that our Executive Director, Professor Michelle Haber AM, has been awarded the Premier’s Award for Outstanding Cancer Researcher of the Year 2014, in recognition of her significant contribution to research into childhood cancer.
New target for cancer therapy.
2014 Researchers at Children’s Cancer Institute have uncovered
for the first time, another gene linked to the cause of one of the most aggressive forms of childhood cancer – that could provide new targets for cancer therapy and change the way we treat the disease.
Governor General announced as Patron.
July 28, 2014 Children’s Cancer Institute is extremely proud to announce that His Excellency General the Honourable Sir Peter Cosgrove AK MC (Retd), Governor-General of the Commonwealth of Australia, has become a Patron for our organisation.
The Byrne Family Story.
June 30, 2014 Brian and Glenda Byrne have endured the almost unbelievable heartbreak of losing three of their four sons – in completely unrelated incidents.
Following the death of their youngest son, Kieran, from a rare form of childhood cancer, their only surviving son, Brendan, received harrowing news about his own daughter, Matilda.
Watch as the family tells its fascinating story.
30 years closer.
May 26, 2014 Internationally renowned medical research organisation, Children’s Cancer Institute, is this year celebrating 30 years since its lab doors first opened.
The milestone was officially launched today at the Institute’s Annual General Meeting.
Personalised medicine explained.
May 2, 2014 As we celebrate 30 years of dedicated medical research into childhood cancer, we are very excited to be at the forefront of a new era in childhood cancer treatment: personalised medicine.
Neuroblastoma: Our battle.
May 2, 2014 “While it’s tough knowing there are children out there suffering with the disease, staying positive isn’t that hard.
The courage of children, and their parents, is an incredible inspiration.” – Dr Daniel CarterMore.
Endure for a cure 2014.
April 9, 2014 On Friday 4 April, close to 100 keen cyclists put foot to pedal at Sydney Motor Sport Park, Eastern Creek in an incredible display of endurance to cure kids’ cancer.
Our brand has changed.
Our purpose won’t.
March 27, 2014 Children’s Cancer Institute unveils a new look as we celebrate 30 years since we first opened our lab doors.
New era in childhood cancer treatment.
March 3, 2014 Children’s Cancer Institute is proud to announce its personalised medicine program for children with cancer as a key partner of the newly-funded Cancer Therapeutics Cooperative Research Centre (CTx).
Researchers uncover cause of childhood leukaemia.
September 25, 2013 Australian researchers at Children’s Cancer Institute and Sydney Children’s Hospital are part of an international research collaboration that has discovered a genetic link specific to the risk of childhood leukaemia.
Green tea extract potential.
2013 Children’s Cancer Institute researcher
Dr Orazio Vittorio, was awarded the inaugural Kids’ Cancer Project award at the NSW Premier’s Awards for Outstanding Cancer Research for research looking at the anti-cancer properties of an antioxidant.
Old drugs bring new hope.
2013 Researchers at Children’s Cancer Institute have discovered that beta-blockers
traditionally used in the treatment of hypertension, can increase the effectiveness of chemotherapy in childhood cancers, such as neuroblastoma.
Antibody drug new hope for blood cancer.
April 22, 2013 Researchers at Children’s Cancer Institute have shown that a new antibody-based drug has the potential to improve the survival rate for children who relapse from one of the most common types of paediatric blood cancers: acute lymphoblastic leukaemia.
Stay up to date with our news, social media channels like Facebook, twitter and Instagram.
Gain insight in to whats happening in our news and media world.
In the media.
Sydney Morning Herald, 15 May 2019: The plan to save children with ‘the worst of the worst’ cancers.
Woman’s Day: Australia’s bravest best friends are beating cancer together.
Mosman Daily: Balmoral Swim – Making a splash for charity.
Manly Daily: Endure for a Cure – On their bikes for brave kids.
Australian Life Scientist: Blood pressure drug boosts effect of chemo.
The Australian: Profs Haber, Marshall & Norris Innovation Challenge Awards finalists.
Seven News: Radical survival plans for children battling cancer.
A Current Affair: Zero Childhood Cancer gives children with brain cancer the best chance yet of surviving.
2UE: Interview with Nikki Quinn, childhood cancer survivor.
On Our Blog.
Older Posts Contact us.
For more information on news and media, please contact our Communications Team:+61 2 9385 8879 [email protected] Facebook Posts.
View on Facebook This message is only visible to admins:Unable to display Facebook postsError: (#10) This endpoint requires the ‘manage_pages’ or ‘pages_read_engagement’ permission or the ‘Page Public Content Access’ feature.
Refer to https://developers.facebook.com/docs/apps/review/login-permissions#manage-pages and https://developers.facebook.com/docs/apps/review/feature#reference-PAGES_ACCESS for details.
Type: OAuthExceptionCode: 10Click here to Troubleshoot.
Please enter an Access Token on the Instagram Feed plugin Settings page Load More.
Follow on Instagram Twitter.
@charles_debock 02/09/2020 September is Childhood Cancer Awareness Month.
Very happy to be part of the team @KidsCancerInst where we work to p… twitter.com/i/web/status/1….
@eddy_meyer 02/09/2020 One of my favourite stories.
Lovely little Ellie is alive and well thanks to amazing science and a dedicated team o… twitter.com/i/web/status/1….
@KidsCancerInst 31/08/2020 Today is the first day of International Childhood Cancer Awareness Month.
Go gold throughout September to honour al… twitter.com/i/web/status/1….
@KidsCancerInst 18/08/2020 The Zero Childhood Cancer Program is Australia’s first personalised medicine program for children with high-risk… twitter.com/i/web/status/1….